世界の滅菌静脈注射（IV）溶液市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Sterile Intravenous (IV) Solution Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4904
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、滅菌静脈注射（IV）溶液の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クリスタロイド、コロイド、その他）、用途別市場規模（医薬品、栄養、血液系製品、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・滅菌静脈注射（IV）溶液の市場動向
・企業の競争状況、市場シェア
・滅菌静脈注射（IV）溶液の種類別市場規模と予測2016-2027（クリスタロイド、コロイド、その他）
・滅菌静脈注射（IV）溶液の用途別市場規模と予測2016-2027（医薬品、栄養、血液系製品、その他）
・滅菌静脈注射（IV）溶液の北米市場規模2016-2027（アメリカ、カナダ）
・滅菌静脈注射（IV）溶液の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・滅菌静脈注射（IV）溶液のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・滅菌静脈注射（IV）溶液の中南米市場規模2016-2027（メキシコ、ブラジル）
・滅菌静脈注射（IV）溶液の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（B. Braun Medical Inc.、Technoflex、Baxter International、ICU Medical, Inc、Mckesson、Amsino、Wallcur、Hebei Guangren Pharmaceutical Technology、Jiangsu Hengfengqiang Biotechnology、Hospira、Jiangsu Hengfengqiang Biotechnology、Hospira、Xi'an Libang Alliance Enterprise Management、Livzon Group）
・結論

Sterile Intravenous (IV), also known as sterile Intravenous therapy is a therapy that delivers liquid which is in medical use into a vein.

Market Analysis and Insights: Global Sterile Intravenous (IV) Solution Market
The global Sterile Intravenous (IV) Solution market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sterile Intravenous (IV) Solution market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sterile Intravenous (IV) Solution market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sterile Intravenous (IV) Solution market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sterile Intravenous (IV) Solution market.

Global Sterile Intravenous (IV) Solution Scope and Market Size
Sterile Intravenous (IV) Solution market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sterile Intravenous (IV) Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Crystalloids
Colloids
Others

Segment by Application
Medications
NutritionNutrition
Blood-based Products
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
B. Braun Medical Inc.
Technoflex
Baxter International
ICU Medical, Inc
Mckesson
Amsino
Wallcur
Hebei Guangren Pharmaceutical Technology
Jiangsu Hengfengqiang Biotechnology
Hospira
Jiangsu Hengfengqiang Biotechnology
Hospira
Xi’an Libang Alliance Enterprise Management
Livzon Group

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sterile Intravenous (IV) Solution Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Crystalloids
1.2.3 Colloids
1.2.4 Others
1.3 Market by Application
1.3.1 Global Sterile Intravenous (IV) Solution Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Medications
1.3.3 NutritionNutrition
1.3.4 Blood-based Products
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Sterile Intravenous (IV) Solution Market Perspective (2016-2027)
2.2 Sterile Intravenous (IV) Solution Growth Trends by Regions
2.2.1 Sterile Intravenous (IV) Solution Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sterile Intravenous (IV) Solution Historic Market Share by Regions (2016-2021)
2.2.3 Sterile Intravenous (IV) Solution Forecasted Market Size by Regions (2022-2027)
2.3 Sterile Intravenous (IV) Solution Industry Dynamic
2.3.1 Sterile Intravenous (IV) Solution Market Trends
2.3.2 Sterile Intravenous (IV) Solution Market Drivers
2.3.3 Sterile Intravenous (IV) Solution Market Challenges
2.3.4 Sterile Intravenous (IV) Solution Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Sterile Intravenous (IV) Solution Players by Revenue
3.1.1 Global Top Sterile Intravenous (IV) Solution Players by Revenue (2016-2021)
3.1.2 Global Sterile Intravenous (IV) Solution Revenue Market Share by Players (2016-2021)
3.2 Global Sterile Intravenous (IV) Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sterile Intravenous (IV) Solution Revenue
3.4 Global Sterile Intravenous (IV) Solution Market Concentration Ratio
3.4.1 Global Sterile Intravenous (IV) Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sterile Intravenous (IV) Solution Revenue in 2020
3.5 Sterile Intravenous (IV) Solution Key Players Head office and Area Served
3.6 Key Players Sterile Intravenous (IV) Solution Product Solution and Service
3.7 Date of Enter into Sterile Intravenous (IV) Solution Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Sterile Intravenous (IV) Solution Breakdown Data by Type
4.1 Global Sterile Intravenous (IV) Solution Historic Market Size by Type (2016-2021)
4.2 Global Sterile Intravenous (IV) Solution Forecasted Market Size by Type (2022-2027)

5 Sterile Intravenous (IV) Solution Breakdown Data by Application
5.1 Global Sterile Intravenous (IV) Solution Historic Market Size by Application (2016-2021)
5.2 Global Sterile Intravenous (IV) Solution Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Sterile Intravenous (IV) Solution Market Size (2016-2027)
6.2 North America Sterile Intravenous (IV) Solution Market Size by Type
6.2.1 North America Sterile Intravenous (IV) Solution Market Size by Type (2016-2021)
6.2.2 North America Sterile Intravenous (IV) Solution Market Size by Type (2022-2027)
6.2.3 North America Sterile Intravenous (IV) Solution Market Size by Type (2016-2027)
6.3 North America Sterile Intravenous (IV) Solution Market Size by Application
6.3.1 North America Sterile Intravenous (IV) Solution Market Size by Application (2016-2021)
6.3.2 North America Sterile Intravenous (IV) Solution Market Size by Application (2022-2027)
6.3.3 North America Sterile Intravenous (IV) Solution Market Size by Application (2016-2027)
6.4 North America Sterile Intravenous (IV) Solution Market Size by Country
6.4.1 North America Sterile Intravenous (IV) Solution Market Size by Country (2016-2021)
6.4.2 North America Sterile Intravenous (IV) Solution Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Sterile Intravenous (IV) Solution Market Size (2016-2027)
7.2 Europe Sterile Intravenous (IV) Solution Market Size by Type
7.2.1 Europe Sterile Intravenous (IV) Solution Market Size by Type (2016-2021)
7.2.2 Europe Sterile Intravenous (IV) Solution Market Size by Type (2022-2027)
7.2.3 Europe Sterile Intravenous (IV) Solution Market Size by Type (2016-2027)
7.3 Europe Sterile Intravenous (IV) Solution Market Size by Application
7.3.1 Europe Sterile Intravenous (IV) Solution Market Size by Application (2016-2021)
7.3.2 Europe Sterile Intravenous (IV) Solution Market Size by Application (2022-2027)
7.3.3 Europe Sterile Intravenous (IV) Solution Market Size by Application (2016-2027)
7.4 Europe Sterile Intravenous (IV) Solution Market Size by Country
7.4.1 Europe Sterile Intravenous (IV) Solution Market Size by Country (2016-2021)
7.4.2 Europe Sterile Intravenous (IV) Solution Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Sterile Intravenous (IV) Solution Market Size (2016-2027)
8.2 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Type
8.2.1 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Type (2016-2027)
8.3 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Application
8.3.1 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Application (2016-2027)
8.4 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Region
8.4.1 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Sterile Intravenous (IV) Solution Market Size (2016-2027)
9.2 Latin America Sterile Intravenous (IV) Solution Market Size by Type
9.2.1 Latin America Sterile Intravenous (IV) Solution Market Size by Type (2016-2021)
9.2.2 Latin America Sterile Intravenous (IV) Solution Market Size by Type (2022-2027)
9.2.3 Latin America Sterile Intravenous (IV) Solution Market Size by Type (2016-2027)
9.3 Latin America Sterile Intravenous (IV) Solution Market Size by Application
9.3.1 Latin America Sterile Intravenous (IV) Solution Market Size by Application (2016-2021)
9.3.2 Latin America Sterile Intravenous (IV) Solution Market Size by Application (2022-2027)
9.3.3 Latin America Sterile Intravenous (IV) Solution Market Size by Application (2016-2027)
9.4 Latin America Sterile Intravenous (IV) Solution Market Size by Country
9.4.1 Latin America Sterile Intravenous (IV) Solution Market Size by Country (2016-2021)
9.4.2 Latin America Sterile Intravenous (IV) Solution Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Sterile Intravenous (IV) Solution Market Size (2016-2027)
10.2 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Type
10.2.1 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Type (2016-2027)
10.3 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Application
10.3.1 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Application (2016-2027)
10.4 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Country
10.4.1 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 B. Braun Medical Inc.
11.1.1 B. Braun Medical Inc. Company Details
11.1.2 B. Braun Medical Inc. Business Overview
11.1.3 B. Braun Medical Inc. Sterile Intravenous (IV) Solution Introduction
11.1.4 B. Braun Medical Inc. Revenue in Sterile Intravenous (IV) Solution Business (2016-2021)
11.1.5 B. Braun Medical Inc. Recent Development
11.2 Technoflex
11.2.1 Technoflex Company Details
11.2.2 Technoflex Business Overview
11.2.3 Technoflex Sterile Intravenous (IV) Solution Introduction
11.2.4 Technoflex Revenue in Sterile Intravenous (IV) Solution Business (2016-2021)
11.2.5 Technoflex Recent Development
11.3 Baxter International
11.3.1 Baxter International Company Details
11.3.2 Baxter International Business Overview
11.3.3 Baxter International Sterile Intravenous (IV) Solution Introduction
11.3.4 Baxter International Revenue in Sterile Intravenous (IV) Solution Business (2016-2021)
11.3.5 Baxter International Recent Development
11.4 ICU Medical, Inc
11.4.1 ICU Medical, Inc Company Details
11.4.2 ICU Medical, Inc Business Overview
11.4.3 ICU Medical, Inc Sterile Intravenous (IV) Solution Introduction
11.4.4 ICU Medical, Inc Revenue in Sterile Intravenous (IV) Solution Business (2016-2021)
11.4.5 ICU Medical, Inc Recent Development
11.5 Mckesson
11.5.1 Mckesson Company Details
11.5.2 Mckesson Business Overview
11.5.3 Mckesson Sterile Intravenous (IV) Solution Introduction
11.5.4 Mckesson Revenue in Sterile Intravenous (IV) Solution Business (2016-2021)
11.5.5 Mckesson Recent Development
11.6 Amsino
11.6.1 Amsino Company Details
11.6.2 Amsino Business Overview
11.6.3 Amsino Sterile Intravenous (IV) Solution Introduction
11.6.4 Amsino Revenue in Sterile Intravenous (IV) Solution Business (2016-2021)
11.6.5 Amsino Recent Development
11.7 Wallcur
11.7.1 Wallcur Company Details
11.7.2 Wallcur Business Overview
11.7.3 Wallcur Sterile Intravenous (IV) Solution Introduction
11.7.4 Wallcur Revenue in Sterile Intravenous (IV) Solution Business (2016-2021)
11.7.5 Wallcur Recent Development
11.8 Hebei Guangren Pharmaceutical Technology
11.8.1 Hebei Guangren Pharmaceutical Technology Company Details
11.8.2 Hebei Guangren Pharmaceutical Technology Business Overview
11.8.3 Hebei Guangren Pharmaceutical Technology Sterile Intravenous (IV) Solution Introduction
11.8.4 Hebei Guangren Pharmaceutical Technology Revenue in Sterile Intravenous (IV) Solution Business (2016-2021)
11.8.5 Hebei Guangren Pharmaceutical Technology Recent Development
11.9 Jiangsu Hengfengqiang Biotechnology
11.9.1 Jiangsu Hengfengqiang Biotechnology Company Details
11.9.2 Jiangsu Hengfengqiang Biotechnology Business Overview
11.9.3 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Introduction
11.9.4 Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2016-2021)
11.9.5 Jiangsu Hengfengqiang Biotechnology Recent Development
11.10 Hospira
11.10.1 Hospira Company Details
11.10.2 Hospira Business Overview
11.10.3 Hospira Sterile Intravenous (IV) Solution Introduction
11.10.4 Hospira Revenue in Sterile Intravenous (IV) Solution Business (2016-2021)
11.10.5 Hospira Recent Development
11.11 Jiangsu Hengfengqiang Biotechnology
11.11.1 Jiangsu Hengfengqiang Biotechnology Company Details
11.11.2 Jiangsu Hengfengqiang Biotechnology Business Overview
11.11.3 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Introduction
11.11.4 Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2016-2021)
11.11.5 Jiangsu Hengfengqiang Biotechnology Recent Development
11.12 Hospira
11.12.1 Hospira Company Details
11.12.2 Hospira Business Overview
11.12.3 Hospira Sterile Intravenous (IV) Solution Introduction
11.12.4 Hospira Revenue in Sterile Intravenous (IV) Solution Business (2016-2021)
11.12.5 Hospira Recent Development
11.13 Xi’an Libang Alliance Enterprise Management
11.13.1 Xi’an Libang Alliance Enterprise Management Company Details
11.13.2 Xi’an Libang Alliance Enterprise Management Business Overview
11.13.3 Xi’an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Introduction
11.13.4 Xi’an Libang Alliance Enterprise Management Revenue in Sterile Intravenous (IV) Solution Business (2016-2021)
11.13.5 Xi’an Libang Alliance Enterprise Management Recent Development
11.14 Livzon Group
11.14.1 Livzon Group Company Details
11.14.2 Livzon Group Business Overview
11.14.3 Livzon Group Sterile Intravenous (IV) Solution Introduction
11.14.4 Livzon Group Revenue in Sterile Intravenous (IV) Solution Business (2016-2021)
11.14.5 Livzon Group Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Sterile Intravenous (IV) Solution Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Crystalloids
Table 3. Key Players of Colloids
Table 4. Key Players of Others
Table 5. Global Sterile Intravenous (IV) Solution Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Sterile Intravenous (IV) Solution Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Sterile Intravenous (IV) Solution Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Sterile Intravenous (IV) Solution Market Share by Regions (2016-2021)
Table 9. Global Sterile Intravenous (IV) Solution Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Sterile Intravenous (IV) Solution Market Share by Regions (2022-2027)
Table 11. Sterile Intravenous (IV) Solution Market Trends
Table 12. Sterile Intravenous (IV) Solution Market Drivers
Table 13. Sterile Intravenous (IV) Solution Market Challenges
Table 14. Sterile Intravenous (IV) Solution Market Restraints
Table 15. Global Sterile Intravenous (IV) Solution Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Sterile Intravenous (IV) Solution Market Share by Players (2016-2021)
Table 17. Global Top Sterile Intravenous (IV) Solution Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sterile Intravenous (IV) Solution as of 2020)
Table 18. Ranking of Global Top Sterile Intravenous (IV) Solution Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Sterile Intravenous (IV) Solution Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sterile Intravenous (IV) Solution Product Solution and Service
Table 22. Date of Enter into Sterile Intravenous (IV) Solution Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sterile Intravenous (IV) Solution Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Sterile Intravenous (IV) Solution Revenue Market Share by Type (2016-2021)
Table 26. Global Sterile Intravenous (IV) Solution Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Sterile Intravenous (IV) Solution Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Sterile Intravenous (IV) Solution Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Sterile Intravenous (IV) Solution Revenue Market Share by Application (2016-2021)
Table 30. Global Sterile Intravenous (IV) Solution Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Sterile Intravenous (IV) Solution Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Sterile Intravenous (IV) Solution Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Sterile Intravenous (IV) Solution Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Sterile Intravenous (IV) Solution Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Sterile Intravenous (IV) Solution Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Sterile Intravenous (IV) Solution Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Sterile Intravenous (IV) Solution Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Sterile Intravenous (IV) Solution Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Sterile Intravenous (IV) Solution Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Sterile Intravenous (IV) Solution Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Sterile Intravenous (IV) Solution Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Sterile Intravenous (IV) Solution Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Sterile Intravenous (IV) Solution Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Sterile Intravenous (IV) Solution Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Sterile Intravenous (IV) Solution Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Sterile Intravenous (IV) Solution Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Sterile Intravenous (IV) Solution Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Sterile Intravenous (IV) Solution Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Sterile Intravenous (IV) Solution Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Country (2022-2027) & (US$ Million)
Table 62. B. Braun Medical Inc. Company Details
Table 63. B. Braun Medical Inc. Business Overview
Table 64. B. Braun Medical Inc. Sterile Intravenous (IV) Solution Product
Table 65. B. Braun Medical Inc. Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million)
Table 66. B. Braun Medical Inc. Recent Development
Table 67. Technoflex Company Details
Table 68. Technoflex Business Overview
Table 69. Technoflex Sterile Intravenous (IV) Solution Product
Table 70. Technoflex Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million)
Table 71. Technoflex Recent Development
Table 72. Baxter International Company Details
Table 73. Baxter International Business Overview
Table 74. Baxter International Sterile Intravenous (IV) Solution Product
Table 75. Baxter International Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million)
Table 76. Baxter International Recent Development
Table 77. ICU Medical, Inc Company Details
Table 78. ICU Medical, Inc Business Overview
Table 79. ICU Medical, Inc Sterile Intravenous (IV) Solution Product
Table 80. ICU Medical, Inc Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million)
Table 81. ICU Medical, Inc Recent Development
Table 82. Mckesson Company Details
Table 83. Mckesson Business Overview
Table 84. Mckesson Sterile Intravenous (IV) Solution Product
Table 85. Mckesson Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million)
Table 86. Mckesson Recent Development
Table 87. Amsino Company Details
Table 88. Amsino Business Overview
Table 89. Amsino Sterile Intravenous (IV) Solution Product
Table 90. Amsino Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million)
Table 91. Amsino Recent Development
Table 92. Wallcur Company Details
Table 93. Wallcur Business Overview
Table 94. Wallcur Sterile Intravenous (IV) Solution Product
Table 95. Wallcur Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million)
Table 96. Wallcur Recent Development
Table 97. Hebei Guangren Pharmaceutical Technology Company Details
Table 98. Hebei Guangren Pharmaceutical Technology Business Overview
Table 99. Hebei Guangren Pharmaceutical Technology Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million)
Table 100. Hebei Guangren Pharmaceutical Technology Recent Development
Table 101. Jiangsu Hengfengqiang Biotechnology Company Details
Table 102. Jiangsu Hengfengqiang Biotechnology Business Overview
Table 103. Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product
Table 104. Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million)
Table 105. Jiangsu Hengfengqiang Biotechnology Recent Development
Table 106. Hospira Company Details
Table 107. Hospira Business Overview
Table 108. Hospira Sterile Intravenous (IV) Solution Product
Table 109. Hospira Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million)
Table 110. Hospira Recent Development
Table 111. Jiangsu Hengfengqiang Biotechnology Company Details
Table 112. Jiangsu Hengfengqiang Biotechnology Business Overview
Table 113. Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product
Table 114. Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million)
Table 115. Jiangsu Hengfengqiang Biotechnology Recent Development
Table 116. Hospira Company Details
Table 117. Hospira Business Overview
Table 118. Hospira Sterile Intravenous (IV) Solution Product
Table 119. Hospira Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million)
Table 120. Hospira Recent Development
Table 121. Xi'an Libang Alliance Enterprise Management Company Details
Table 122. Xi'an Libang Alliance Enterprise Management Business Overview
Table 123. Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Product
Table 124. Xi'an Libang Alliance Enterprise Management Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million)
Table 125. Xi'an Libang Alliance Enterprise Management Recent Development
Table 126. Livzon Group Company Details
Table 127. Livzon Group Business Overview
Table 128. Livzon Group Sterile Intravenous (IV) Solution Product
Table 129. Livzon Group Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million)
Table 130. Livzon Group Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sterile Intravenous (IV) Solution Market Share by Type: 2020 VS 2027
Figure 2. Crystalloids Features
Figure 3. Colloids Features
Figure 4. Others Features
Figure 5. Global Sterile Intravenous (IV) Solution Market Share by Application: 2020 VS 2027
Figure 6. Medications Case Studies
Figure 7. NutritionNutrition Case Studies
Figure 8. Blood-based Products Case Studies
Figure 9. Others Case Studies
Figure 10. Sterile Intravenous (IV) Solution Report Years Considered
Figure 11. Global Sterile Intravenous (IV) Solution Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Sterile Intravenous (IV) Solution Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Sterile Intravenous (IV) Solution Market Share by Regions: 2020 VS 2027
Figure 14. Global Sterile Intravenous (IV) Solution Market Share by Regions (2022-2027)
Figure 15. Global Sterile Intravenous (IV) Solution Market Share by Players in 2020
Figure 16. Global Top Sterile Intravenous (IV) Solution Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sterile Intravenous (IV) Solution as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Sterile Intravenous (IV) Solution Revenue in 2020
Figure 18. Global Sterile Intravenous (IV) Solution Revenue Market Share by Type (2016-2021)
Figure 19. Global Sterile Intravenous (IV) Solution Revenue Market Share by Type (2022-2027)
Figure 20. North America Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Sterile Intravenous (IV) Solution Market Share by Type (2016-2027)
Figure 22. North America Sterile Intravenous (IV) Solution Market Share by Application (2016-2027)
Figure 23. North America Sterile Intravenous (IV) Solution Market Share by Country (2016-2027)
Figure 24. United States Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Sterile Intravenous (IV) Solution Market Share by Type (2016-2027)
Figure 28. Europe Sterile Intravenous (IV) Solution Market Share by Application (2016-2027)
Figure 29. Europe Sterile Intravenous (IV) Solution Market Share by Country (2016-2027)
Figure 30. Germany Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Sterile Intravenous (IV) Solution Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Sterile Intravenous (IV) Solution Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Sterile Intravenous (IV) Solution Market Share by Region (2016-2027)
Figure 40. China Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Sterile Intravenous (IV) Solution Market Share by Type (2016-2027)
Figure 48. Latin America Sterile Intravenous (IV) Solution Market Share by Application (2016-2027)
Figure 49. Latin America Sterile Intravenous (IV) Solution Market Share by Country (2016-2027)
Figure 50. Mexico Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Sterile Intravenous (IV) Solution Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Sterile Intravenous (IV) Solution Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Sterile Intravenous (IV) Solution Market Share by Country (2016-2027)
Figure 56. Turkey Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. B. Braun Medical Inc. Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021)
Figure 60. Technoflex Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021)
Figure 61. Baxter International Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021)
Figure 62. ICU Medical, Inc Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021)
Figure 63. Mckesson Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021)
Figure 64. Amsino Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021)
Figure 65. Wallcur Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021)
Figure 66. Hebei Guangren Pharmaceutical Technology Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021)
Figure 67. Jiangsu Hengfengqiang Biotechnology Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021)
Figure 68. Hospira Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021)
Figure 69. Jiangsu Hengfengqiang Biotechnology Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021)
Figure 70. Hospira Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021)
Figure 71. Xi'an Libang Alliance Enterprise Management Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021)
Figure 72. Livzon Group Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

以下、関連資料のご紹介

世界の滅菌注射市場規模・現状・予測（2021年-2027年）

Global Sterile Injection Market Size, Status and Forecast 2021-2027
QFJ1-6021 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、滅菌注射の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、インスリン、免疫グロブリン、サイトカイン、血液因子、その他）、用途別市場規模（腫瘍、循環器疾患、感染症、糖尿病、その他）、主...

世界の静脈内（IV）鉄投与療法市場規模・現状・予測（2021年-2027年）

Global Intravenous (IV) Iron Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4394 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、静脈内（IV）鉄投与療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カルボキシマルトース鉄、鉄スクロース、鉄デキストラン、その他）、用途別市場規模（腎臓内科、婦人科・産科、消化器内科、腫瘍内科、循...

世界の静脈内（IV）療法＆静脈アクセス市場規模・現状・予測（2021年-2027年）

Global Intravenous(IV) Therapy and Vein Access Market Size, Status and Forecast 2021-2027
QFJ1-4395 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、静脈内（IV）療法＆静脈アクセスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（輸液ポンプ、植込み型ポート、静脈注射カテーテル、皮下注射針、その他）、用途別市場規模（病院、クリニック、その他）、主要地...

世界の静脈内チューブセット＆付属品市場規模・現状・予測（2021年-2027年）

Global Intravenous Tubing Sets and Accessories Market Size, Status and Forecast 2021-2027
QFJ1-5217 2021年6月 119Pages
QYResearch社発行の本調査レポートでは、静脈内チューブセット＆付属品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（IVセット、カニューレ、チューブ、針、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場...

世界の自閉症治療市場規模・現状・予測（2021年-2027年）

Global Autism Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3869 2021年6月 123Pages
QYResearch社発行の本調査レポートでは、自閉症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（セロトニン摂取阻害剤（SSRI）、不眠症治療薬、抗痙攣薬、抗精神病薬、その他）、用途別市場規模（病院薬局、販売店薬局、オンライン薬局、その他）...

静脈内投与溶液のグローバル市場2021

Global Intravenous Solutions Sales Market Report 2021
QAF27748 2021年4月14日 135Pages
本市場調査資料では、世界の静脈内投与溶液市場について種類別（クリスタロイド、コロイド、その他）、用途別（基本IV投与、栄養注入投与、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、...

世界のラコサミド市場規模・現状・予測（2021年-2027年）

Global Lacosamide Market Size, Status and Forecast 2021-2027
QFJ1-5827 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、ラコサミドの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口錠剤、経口液剤、静脈注射）、用途別市場規模（成人、小児患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界の超音波画像ソリューション市場規模・現状・予測（2021年-2027年）

Global Ultrasound Imaging Solution Market Size, Status and Forecast 2021-2027
QFJ1-4994 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、超音波画像ソリューションの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（統合型ソフトウェア超音波画像ソリューション、スタンドアロン型ソフトウェア超音波画像ソリューション）、用途別市場規模（病院、クリ...

世界の全身放射線療法市場規模・現状・予測（2021年-2027年）

Global Systemic Radiotherapy Market Size, Status and Forecast 2021-2027
QFJ1-5357 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、全身放射線療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（静脈内放射線療法、経口放射線療法、点滴放射線療法）、用途別市場規模（病院、独立放射線治療センター）、主要地域別市場規模（北米、アメリカ、欧...

静注用免疫グロブリン（IVIg）のグローバル市場2021

Global Intravenous Immunoglobulin (IVIg) Sales Market Report 2021
QAF27747 2021年3月31日 144Pages
本市場調査資料では、世界の静注用免疫グロブリン（IVIg）市場について種類別（IVIg液、IVIg粉）、用途別（免疫不全症、自己免疫疾患、急性感染症）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上...

世界の滅菌注射市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sterile Injection Market The global Sterile Injection market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…
滅菌医療包装のグローバル市場2021 Sterile Medical Packaging is supplied in sterile conditions by the manufacture companies after the sterilization. With the development of the pharmaceutical industry, the medical instruments and the medicine has higher and higher quality demand in the sterile, because the medical instruments and the…
特殊ビニール袋（実験室用滅菌ビニール袋）のグローバル市場2021 Special Plastic Bags (Laboratory Sterile Plastic Bags) in this report refer to sterile plastic bags used in laboratories, usually sterilized sampling bags. Major producers in the industry include Nasco, Labplas, com-pac International, etc. The top three producers account for more than 42% of the tot…
静脈内投与溶液のグローバル市場2021 Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which …
世界の静脈内（IV）鉄投与療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Intravenous (IV) Iron Therapy Market The global Intravenous (IV) Iron Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…